Group 1 - The core point of the news is that Chuaning Bio experienced a decline of 5.05% in its stock price, reaching 11.29 yuan per share, with a trading volume of 448 million yuan and a turnover rate of 6.33%, resulting in a total market capitalization of 25.178 billion yuan [1] - Chuaning Bio, established on December 10, 2010, and listed on December 27, 2022, is located in the Yili Kazakh Autonomous Prefecture of Xinjiang and focuses on the research and industrialization of biological fermentation technology. The main business revenue composition is 92.81% from pharmaceutical intermediates and 7.19% from other sources [1] Group 2 - From the perspective of major fund holdings, one fund under Qianhai Kaiyuan holds a significant position in Chuaning Bio. The Qianhai Kaiyuan Hong Kong-Shenzhen Innovation Growth Mixed A Fund (002666) held 340,700 shares in the third quarter, accounting for 1.02% of the fund's net value, ranking as the seventh largest holding. The estimated floating loss today is approximately 204,400 yuan [2] - The Qianhai Kaiyuan Hong Kong-Shenzhen Innovation Growth Mixed A Fund (002666) was established on June 24, 2016, with a current scale of 270 million yuan. Year-to-date returns are 0.33%, ranking 8095 out of 8840 in its category; the one-year return is 13.67%, ranking 5997 out of 8094; and the cumulative return since inception is 62.27% [2]